We track avoidable escalations of care associated with chronic edema and lymphatic disease—especially episodes driven by cellulitis risk, skin breakdown, and uncontrolled swelling. Rates are trended over time for enrolled patients using available utilization notifications and documented clinical events. When additional data feeds are available, results are validated against partner-provided utilization reporting.
We track avoidable escalations of care associated with chronic edema and lymphatic disease—especially episodes driven by cellulitis risk, skin breakdown, and uncontrolled swelling. Rates are trended over time for enrolled patients using available utilization notifications and documented clinical events. When additional data feeds are available, results are validated against partner-provided utilization reporting.
We monitor skin integrity at every visit and document changes such as new breakdown, worsening drainage, signs of infection risk, and need for escalation to the referring provider. Complication rates are tracked as documented clinical events over time for the enrolled population. This is paired with adherence to compression, skin care routines, and early identification workflows that reduce preventable deterioration.
We monitor skin integrity at every visit and document changes such as new breakdown, worsening drainage, signs of infection risk, and need for escalation to the referring provider. Complication rates are tracked as documented clinical events over time for the enrolled population. This is paired with adherence to compression, skin care routines, and early identification workflows that reduce preventable deterioration.
Time to first visit is calculated as the number of calendar days from receipt of a complete referral (required demographics, clinical indication, and payer information) to the first completed in-home evaluation/visit. We track this across all new-start patients during the measurement window and monitor delays separately (referral completeness, authorization timing, patient scheduling barriers).
Time to first visit is calculated as the number of calendar days from receipt of a complete referral (required demographics, clinical indication, and payer information) to the first completed in-home evaluation/visit. We track this across all new-start patients during the measurement window and monitor delays separately (referral completeness, authorization timing, patient scheduling barriers).
Admissions are tracked during active enrollment using documented patient/caregiver reports, provider updates, and care coordination records. When available, partner utilization reporting is used to validate trends. The reported change reflects admissions during the measurement window, with focus on edema-driven triggers (infection risk, skin breakdown, uncontrolled swelling).
Admissions are tracked during active enrollment using documented patient/caregiver reports, provider updates, and care coordination records. When available, partner utilization reporting is used to validate trends. The reported change reflects admissions during the measurement window, with focus on edema-driven triggers (infection risk, skin breakdown, uncontrolled swelling).
